Subtype
Malignant Bone Neoplasm
CI-CAN-00001109Explore in graph →
38 active trials4 approved drugs8 evidence items
- NCIt
- C4016
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001109Explore in graph →
Clinical trials
152 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (18)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06008483 | A Dose Finding Study to Treat Bone Tumor(s) | terminated | Phase 1 | 5 | QSAM Therapeutics, Inc.INDUSTRY | 1 | Jul 23, 2026 | clinicaltrials |
| NCT03420963 | Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors | terminated | Phase 1 | 12 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT04410042 |
| Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure |
| terminated |
| Phase 3 |
| 15 |
| St. Jude Children's Research HospitalOTHER |
| 1 |
| Dec 20, 2024 |
| clinicaltrials |
| NCT04740749 | Longevity, Functional Status and Quality of Life of the Compress® Compliant Pre-Stress System(Compress) | terminated | N/A | 200 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT03525392 | Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. | terminated | Phase 1 | 14 | IpsenINDUSTRY | 5 | Dec 12, 2023 | clinicaltrials |
| NCT03468075 | Gemcitabine Plus Ascorbate for Sarcoma in Adults | terminated | Phase 2 | 10 | Mohammed Milhem, MBBSOTHER | 1 | Dec 10, 2020 | clinicaltrials |
| NCT02199938 | Identification and Characterization of Molecular Markers in Musculoskeletal Tumors | terminated | — | 50 | Balgrist University HospitalOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT02775799 | National Swiss Sarcoma Cohort Study(SwissSARCOS) | terminated | — | 50 | Balgrist University HospitalOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT00960063 | A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) | terminated | Phase 1 | 4 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 27, 2018 | clinicaltrials |
| NCT02443103 | Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis | terminated | N/A | 4 | Kathy MillerOTHER | 1 | Feb 13, 2018 | clinicaltrials |
| NCT01313884 | Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma | terminated | Phase 2 | 3 | Stanford UniversityOTHER | 1 | Nov 24, 2017 | clinicaltrials |
| NCT03002454 | Sodium Pertechnetate (99Tc) Injection Generator: 99mTc From Neutron-activation 99Mo v 99mTc From Fission 99Mo | terminated | Phase 3 | 4 | University of ManitobaOTHER | 1 | Oct 3, 2017 | clinicaltrials |
| NCT01541358 | Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer | terminated | N/A | 2 | Stanford UniversityOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT01163539 | Cyberknife Radiosurgery and Quality of Life | terminated | — | 15 | Stanford UniversityOTHER | 1 | Jul 1, 2016 | clinicaltrials |
| NCT00632294 | Retrospective Study of the Biomechanical Properties of Large Allografts | terminated | — | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00127387 | Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia | terminated | Phase 2 / Phase 3 | 54 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jun 26, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Jul 23, 2026source: clinicaltrials